News & Views

Off-Label Promotion Can Increase Qui Tam Fraud Risk

Off-Label Promotion Can Increase Qui Tam Fraud Risk
Drug Industry Daily
December 19, 2003

Considered a novel use of the False Claims Act, Nolan Auerbach partner Kenneth Nolan stressed, in a 2003 interview with Drug Investor Daily, that the Act could be used against pharmaceutical companies that were illegally off-label marketing their drugs. “If you have that efficacy issue, or lack thereof, based on active marketing of unlabeled uses, it adds more fuel to the fire … and those types of situations are out there, unfortunately,” said Nolan. Since this interview, Nolan Auerbach has assisted the government in recovering over $1 billion from pharmaceutical companies that were illegally off-label promoting their drugs.

OUR PROMISE Being a healthcare whistleblower can feel like David taking on Goliath. We help level the playing field.

Our law practice is dedicated exclusively to representing healthcare whistleblowers who are willing to take a stand against unscrupulous corporations that are ripping off our government. Whether the fraud involves __________, we pride ourselves on unparalleled level of service, support and legal assistance for our clients.

    Contact Us

    Contact Us

    The more detailed the response, the more likely it is that we will be able to evaluate and determine if your potential False Claims Act case falls within our case requirements. IF IT DOES, WE WILL RESPOND TO YOU WITHIN 24 HOURS. (Names of potential defendants are not necessary at this point, should you feel more comfortable omitting them.) By law, all communications to us are 100% confidential.

    No. of Employees at the Company?
    Please read the following statement and then click "Send Form":

    Any response to your e-mail will be solely to communicate about our possible representation of you under the qui tam provisions of the False Claims Act. All e-mails submitted to us, whether we take your case or not, are 100% confidential. If we do not respond to your e-mail, then you have communicated information which we cannot address because it appears to fall outside of the False Claims Act or our case requirements.